- transcosmos partners with Tokyo University of Pharmacy and Life Sciences (TUPLS) to address Japan’s projected pharmacist shortage by 2040.
- The collaboration integrates pharmaceutical education with digital transformation (DX) and business process outsourcing (BPO) to improve efficiency and community healthcare.
- Programs aim to develop next-generation pharmacists equipped with technical, operational, and digital skills to sustain quality medical services nationwide.
transcosmos has announced a strategic partnership with the Tokyo University of Pharmacy and Life Sciences (TUPLS) to tackle one of Japan’s most pressing future healthcare challenges: the anticipated pharmacist shortage known as the 2040 Problem. The collaboration, formalized under a Partnership Agreement on Promoting Pharmacist Operational Transformation, seeks to leverage the expertise of both an educational institution and a private-sector company to improve pharmaceutical education and community medical services while developing next-generation healthcare talent.
Japan faces a growing strain on its healthcare system as the population ages, with second-generation baby boomers set to reach 65 and older by 2040. This demographic shift is expected to increase medical demand while reducing the number of available medical professionals, particularly pharmacists, in communities across the country. By combining TUPLS’s extensive knowledge in pharmaceutical sciences with transcosmos’s experience in digital transformation (DX) and business process outsourcing (BPO), the partnership aims to streamline pharmacist operations, enhance efficiency, and maintain the quality of care even in areas facing critical workforce shortages.
The initiative will involve a mix of education and research, creating programs that integrate professional pharmaceutical expertise with DX and BPO technologies. These programs will not only address current operational challenges but also prepare future pharmacists to thrive in a rapidly evolving medical environment. By developing educational pathways that emphasize both technical skills and digital proficiency, the collaboration seeks to nurture next-generation talent capable of supporting sustainable, community-based medical services.
As Japan advances its Community-based Integrated Care System, pharmacists are expected to take on broader roles in local healthcare networks. The partnership encourages the adoption of digital tools and innovative operational strategies to increase efficiency, enabling pharmacists to focus on patient care while optimizing workflow. TUPLS and transcosmos will work closely to research and implement new services that enhance pharmacy operations, helping communities cope with the projected shortage of professionals and resources.
Also Read: Challenges and Opportunities in Higher Education of Clinical Research
“We are excited to have the opportunity to utilize transcosmos’s DX and BPO expertise for student education and research to address challenges that future pharmacists and medical professionals will face”, said Yoshihiro Mimaki, President of TUPLS. He emphasized that this industry-academia collaboration will contribute to the development of talent capable of responding to the evolving needs of Japan’s healthcare system, promoting operational efficiency and resilience in community medical services.
Satoshi Takayama, Corporate Executive Officer of transcosmos, highlighted the importance of applying the company’s long-standing expertise in digital transformation and process optimization to support pharmacists in addressing the 2040 Problem. He noted that the partnership represents an opportunity to advance both research and education in ways that will equip the next generation of healthcare professionals with the skills required to lead the medical field of the future.
Through this innovative collaboration, transcosmos and TUPLS aim to build a sustainable, efficient, and digitally empowered pharmacy workforce. By integrating cutting-edge technologies with professional education, the partnership sets a model for how academia and industry can join forces to address societal challenges, ensuring that communities across Japan have access to high-quality medical services well into the future.
